Record quarterly revenue of $141.1 million, up 25% QoQ and up 179% YoY Fiscal 2024 record revenue of $396.3 million, up 242% versus the prior yearRamping across diverse set of customers and platforms ...

With numerous day trading chart providers available in the market, choosing the right one can be a daunting task. To assist you in this endeavor, Benzinga has compiled a comparison list of some of ...

Whether you want to upgrade, or add more storage to your PCIe 4.0 computer, there’s an SSD for you. Read on to learn more, including what to look for in PCIe 4.0 SSD. Why you should trust us ...

The initial public offering (IPO) of Hexaware Technologies shall open for bidding on Wednesday, February 12. The IT solutions player is offering its shares in the range of Rs 675-708 apiece.

Below is a twelve month price history chart comparing the stock performance of SSD, EL, and POST: Below is a summary table of the current analyst target prices discussed above: ...

This time, the company plans to sell $1 billion worth of stock and hit an $11.5 billion valuation in its planned IPO. That’s how the math works out for a proposed offering it announced Tuesday ...

The best SSD for PS5 is a worthwhile investment and can significantly improve your experience with Sony’s console. Many of the best PS5 games like Call of Duty: Black Ops 6 can take up well over ...

First Trust Us Ipo Index Ucits Etf is listed in the sector. First Trust Us Ipo Index Ucits Etf is listed on the Euronext Paris trading with ticker code FPXU.PA. It has a market capitalisation of $ ...

Fast fashion retailer Shein's plans to list in London face a challenge from a group campaigning against forced labor in China, which said on Monday it would apply for a judicial review of the IPO ...

The non-institutional investors' portion was subscribed 39%. The company raised over Rs 875.5 crore from anchor investors ahead of the IPO. The price band for the issue was set at Rs 382-402 per share ...

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...